" /> XRP6258 - CISMeF





Preferred Label : XRP6258;

MeSH note : in multicenter phase II study for treatment of taxane-resistant metastatic breast cancer patients (2008);

Is substance : O;

Details


You can consult :


Nous contacter.
01/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.